FDA requires updates to labeling for promethazine hydrochloride injection products

[12/27/2023] FDA is alerting health care professionals of labeling updates intended to further reduce the risk of severe chemical irritation and damage to tissues from intravenous administration of promethazine hydrochloride injection.